There are many different ways to show how performance has weakened in recent quarters (I define recent as the last ~18 months).
The most important is probably cashflow but you could equally look at cost trends. The large cut of the dividend is another. Cashflow numbers would likely look worse without the gold price pumping in FY21.
The share price has often fallen on quarterly releases which shows that the production numbers have missed analyst expectations.
I don’t really understand why there isn’t more hard questioning of the company performance from shareholders here. Even by Hotcopper standards there is a level of defensiveness that baffles me. The share price is not just down in the last couple of years due to the gold price. I haven’t held the stock for a few years, I just keep an eye on it to get a view of the local gold sector.
- Forums
- ASX - By Stock
- EVN
- Ann: March 2022 Quarterly Report
Ann: March 2022 Quarterly Report, page-35
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EVN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.61 |
Change
0.120(2.67%) |
Mkt cap ! $9.110B |
Open | High | Low | Value | Volume |
$4.54 | $4.61 | $4.52 | $22.40M | 4.913M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 92212 | $4.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.61 | 26085 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
78 | 74735 | 4.580 |
38 | 82219 | 4.570 |
23 | 105679 | 4.560 |
15 | 50675 | 4.550 |
14 | 60713 | 4.540 |
Price($) | Vol. | No. |
---|---|---|
4.590 | 45876 | 42 |
4.600 | 120694 | 34 |
4.610 | 54320 | 15 |
4.620 | 73236 | 11 |
4.630 | 141289 | 9 |
Last trade - 14.44pm 15/11/2024 (20 minute delay) ? |
Featured News
EVN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online